Half-year report · Q2
7133.TEDINET S100UP3P
Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks11 of 11 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.7bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥8.3bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Operating income | ¥449m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥435m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥717m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥435m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥291m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥441m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥291m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥6.9bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥6.4bn | at 2024-03-31 | Cons. | Assets |
| Total liabilities | ¥5.0bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥4.7bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.9bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥1.6bn | at 2024-03-31 | Cons. | Net assets |
| Cash and deposits | ¥889m | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥688m | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥889m | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥688m | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥188m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥707m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥188m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥201m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥539m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥41.03 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥62.05 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥39.62 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥59.26 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 28.0% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.9% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 19
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥420,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥420,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | −¥4m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥296m |
| jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3.4bn |
| jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3.4bn |
| jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥277m |
| jpcrp040300-q2r_E37198-000Kirari Primereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥544m |
| jpcrp040300-q2r_E37198-000Kirari Primereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥544m |
| jpcrp040300-q2r_E37198-000Kirari Primereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥338m |
| jpcrp040300-q2r_E37198-000Primary Care Homereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥759m |
| jpcrp040300-q2r_E37198-000Primary Care Homereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥759m |
| jpcrp040300-q2r_E37198-000Primary Care Homereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥134m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥749m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥745m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 331
| Item | Context | Value | Unit |
|---|---|---|---|
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0304 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 197000 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0278 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 158000 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0222 | |
| Number of shares held | CurrentQuarterInstant | 5719000 | |
| Shareholding ratio | CurrentQuarterInstant | 0.8053 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 147100 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 7099500 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 70995 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 1800 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 7248400 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 70995 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 147100 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 147100 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0203 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 147100 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 147100 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0203 | |
| Cash and deposits | Prior1YearInstant | 688010000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 888896000 | JPY |
| Accounts receivable trade | Prior1YearInstant | 1498284000 | JPY |
| Accounts receivable trade | CurrentQuarterInstant | 1657526000 | JPY |
| Merchandise | Prior1YearInstant | 181322000 | JPY |
| Merchandise | CurrentQuarterInstant | 238372000 | JPY |
| Other ca | Prior1YearInstant | 77304000 | JPY |
| Other ca | CurrentQuarterInstant | 109647000 | JPY |
| Current assets | Prior1YearInstant | 2444922000 | JPY |
| Current assets | CurrentQuarterInstant | 2894441000 | JPY |
| Buildings net | Prior1YearInstant | 2613021000 | JPY |
| Buildings net | CurrentQuarterInstant | 2581543000 | JPY |
| Other net ppe | Prior1YearInstant | 384378000 | JPY |
| Other net ppe | CurrentQuarterInstant | 462097000 | JPY |
| Property plant and equipment | Prior1YearInstant | 2997400000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 3043640000 | JPY |
| Intangible assets | Prior1YearInstant | 364285000 | JPY |
| Intangible assets | CurrentQuarterInstant | 363260000 | JPY |
| Investments and other assets | Prior1YearInstant | 548387000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 598785000 | JPY |
| Noncurrent assets | Prior1YearInstant | 3910073000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 4005687000 | JPY |
| Assets | Prior1YearInstant | 6354996000 | JPY |
| Assets | CurrentQuarterInstant | 6900129000 | JPY |
| Accounts payable trade | Prior1YearInstant | 751779000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 11 of 11 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |